John Beadle is co-founder and managing partner of Aegis Ventures. Since Aegis’s inception, he has led the studio’s executive functions and efforts to tackle healthcare’s biggest challenges, from clinician burnout to health equity and financial sustainability. John was the architect of Aegis Ventures’ $100 million partnership with Northwell Health, New York’s largest health system and private employer. This innovative partnership combines Northwell’s diverse, generalizable datasets and implementation sandbox with leading medical, technology, and business resources within a single, fully integrated ecosystem. To date, the partnership has resulted in the launch of five new companies – Ascertain (back office process automation), Caire (patient & provider platform), Upliv (women’s health), Optain (ophthalmic imaging), and Hume AI (emotion analytics). John sits on each company’s Board of Directors. Before launching Aegis Ventures in 2020, John spent five years at APL Group, a global private equity firm and Aegis’s sister company, where he led an investment team focused on the development of new business lines on a global basis. Prior to APL, John worked in primary investments at John Laing Group and investment banking at Bank of America Merrill Lynch. The son of a nurse, John has always had a passion for healthcare. He earned his BA from Harvard College, where he focused on the US business-government relationship, with an emphasis on health policy, and his MS in Global Affairs from Tsinghua University as a Schwarzman Scholar.

Mark H. Michalski, MD is the CEO of Ascertain, a healthcare AI company creation platform focused on merging deep technical and clinical expertise to deliver high-quality, equitable, and affordable healthcare. Previously, Dr. Michalski was faculty at Harvard Medical School, where he launched the Center for Clinical Data Science (CCDS)—a research center of excellence embedded within the world-class Mass Gen Brigham provider system. The CCDS launched over a dozen AI/ML solutions, and secured strategic partnerships with GE, Nvidia, Nuance, and Fuji to commercialize its technology. Dr. Michalski has held leadership and operational roles at early-stage companies in the medical software and device domain, including Butterfly Network (a point-of-care ultrasound company) as president and CMO and Hyperfine Research (a portable MRI system company) as CMO. Both organizations successfully went public in 2021. Dr. Michalski has also worked at the intersection of technology and drug development, working with global biopharma clients as the AI/ML practice lead at Headland Strategy Group, and held additional life science-focused roles at Google and Genentech. Most recently. Dr. Michalski was the Worldwide Head Healthcare & Life Sciences AI/ML BD at Amazon/AWS, where he worked with strategic healthcare and life science partners to advance AI/ML in the cloud. Dr. Michalski completed his radiology residency training as a Holman Fellow at Yale-New Haven Hospital. He graduated with a degree in Cybernetics from the University of California at Los Angeles with multiple honors and received his medical degree from Stanford University.

Madhu Ravella is the Chief Product Officer of Caire. Madhu previously served as the Senior Vice President of Signify Health, a provider of home-based care to older adults. She spent five years as Vice President of Population Health Services at Optum, working closely with employers, payors and providers. She was also an early member of the Sun Microsystems (acq. Oracle) product team. Madhu is passionate about addressing gaps in care, access and cost across underserved populations by utilizing data-driven, innovative solutions. She is based in Dallas.

Marc Brown is the Chief Technology Officer of Caire. Prior to Caire, Marc was an Engineering Director at Ro, where he oversaw multiple teams within the Patient Care group. He previously co-founded and launched a startup in the Health & Wellness space. Marc has over 20 years of experience building applications and leading Engineering teams at various companies and is passionate about leveraging data-driven decision-making to help people live happier, healthier lives. He is based in New York City.

Dr. John H. Noseworthy is Executive Chairman of Caire and also serves as Chairman of the Digital Consortium, a group of leading regional health systems (still in stealth) that will partner to build, launch, and deploy digital health products that address core challenges in care delivery and operational efficiency. Dr. Noseworthy is also President and CEO Emeritus of Mayo Clinic. During his tenure as CEO, Mayo became a leading global hub of healthtech innovation, the number-one ranked hospital in the world, and the number-one ranked location for destination medicine. John also led the development of Mayo Clinic Care Network, a consortium of 45 health systems aimed at facilitating special access to Mayo Clinic's knowledge and expertise. Prior to his appointment as CEO, John served as Chair of Mayo Clinic's Department of Neurology and Editor-in-Chief of Neurology. In addition to his leadership roles at Mayo, John has served on the Boards of United Health Group, Merck, AlixPartners and the World Economic Forum.

Tim Best is Founder and CEO of Avtur Ventures, a boutique advisory firm which serves C-Suite executives leading the largest health systems. In his previous role, Tim was Managing Principle, Health System Strategic Growth at The Health Management Academy, where he was a thought partner to health system executives seeking new ways to collaborate with one another. Tim’s prior experience includes roles at Shields Health Solutions, where he was Head of Strategic Partnerships, and at Pfizer, where he was a Senior Director responsible for leading a new go-to-market strategy to address the consolidation of health care providers into integrated delivery systems.